Description
Uropass-D is a combination medication designed to treat the signs and symptoms of Benign Prostatic Hyperplasia (BPH), commonly known as an enlarged prostate. This condition can lead to urinary difficulties such as frequent urination, urgency, weak stream, and incomplete bladder emptying.The dual-action formulation combines:
-
Tamsulosin Hydrochloride: An alpha-1 adrenergic receptor antagonist that selectively targets receptors in the prostate and bladder neck, leading to muscle relaxation and improved urine flow.
-
Dutasteride: A 5-alpha reductase inhibitor that reduces the production of dihydrotestosterone (DHT), a hormone responsible for prostate growth, thereby reducing prostate size over time.
Together, these components address both the dynamic and static components of BPH, improving urinary symptoms and reducing the risk of acute urinary retention and the need for surgery.
.png)
.jpeg)
.png)
.webp)
.png)
.jpeg)
.jpeg)
.webp)
.webp)
Change Language